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Abstract
Background: Ageing is associated with changes in the immune system with substantial alterations in T-
lymphocyte subsets. Cytomegalovirus (CMV) is one of the factors that affect functionality of T cells and
the differentiation and large expansions of CMV pp65-specific T cells have been associated with impaired
responses to other immune challenges. Moreover, the presence of clonal expansions of CMV-specific T
cells may shrink the available repertoire for other antigens and contribute to the increased incidence of
infectious diseases in the elderly. In this study, we analyse the effect of ageing on the phenotype and
frequency of CMV pp65-specific CD8 T cell subsets according to the expression of CCR7, CD45RA,
CD27, CD28, CD244 and CD85j.
Results: Peripheral blood from HLA-A2 healthy young, middle-aged and elderly donors was analysed by
multiparametric flow cytometry using the HLA-A*0201/CMV pp65495–504 (NLVPMVATV) pentamer and
mAbs specific for the molecules analysed. The frequency of CMV pp65-specific CD8 T cells was increased
in the elderly compared with young and middle-aged donors. The proportion of naïve cells was reduced
in the elderly, whereas an age-associated increase of the CCR7null effector-memory subset, in particular
those with a CD45RAdim phenotype, was observed, both in the pentamer-positive and pentamer-negative
CD8 T cells. The results also showed that most CMV pp65-specific CD8 T cells in elderly individuals were
CD27/CD28 negative and expressed CD85j and CD244.
Conclusion: The finding that the phenotype of CMV pp65-specific CD8 T cells in elderly individuals is
similar to the predominant phenotype of CD8 T cells as a whole, suggests that CMV persistent infections
contributes to the age-related changes observed in the CD8 T cell compartment, and that chronic
stimulation by other persistent antigens also play a role in T cell immunosenescence. Differences in subset
distribution in elderly individuals showing a decrease in naive and an increase in effector-memory CD8 T
cells may be relevant in the age-associated defective immune response.
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Background
Human cytomegalovirus (CMV) infection in immuno-
competent individuals is normally asymptomatic, but can
be a major cause of morbility in immunosuppressed indi-
viduals. After primary infection the virus persists through-
out life in a latent form in a variety of tissues, particularly
in precursor cells of the monocytic lineage [1]. Host
defence against infection by CMV is ensured in great part
by cytotoxic CD8 T lymphocytes directed against the teg-
ument protein pp65 [2]. In immunosuppressed, and
occasionally immunocompetent persons, CMV can be
reactivated and, in these situations, the presence of CMV-
specific CD8 T cells which are not producing IFNγ, and
therefore potentially anergic or in vivo exhausted is fre-
quent [3].
Ageing is associated with changes in the immune system
with substantial alterations in T-lymphocyte subsets. CMV
infection substantially modulates the peripheral lym-
phoid pool in healthy donors [4,5]. CMV also affects func-
tionality of T cells and the differentiation and large
expansion of CMV-specific T cells have been associated
with impaired responses to other immune challenges [6].
Moreover, clonal expansions of CMV-specific T cells may
shrink the available repertoire for other antigens and con-
tribute to the increased incidence of infectious disease in
the elderly [7-10]. In aged people, the CMV phosphopro-
tein pp65 (UL83) is the major antigen recognised by T
lymphocytes targeting functionally efficient T cell effector
responses with massive production of Th1 cytokines and
exhibition of CD107a degranulation marker [11]. The
percentage of these cells are strikingly expanded and the
great majority are CD28-[12,13]. In addition the CD8 T
cell subset shows a significant increase of the CD45RA+
CD27- subset, likely as a consequence of acute CMV infec-
tion [14].
The pool of memory T cells functions as a dynamic repos-
itory of antigen-experienced T lymphocytes that accumu-
late over the individual's lifetime. Several subpopulations
of human CD8 T cells are defined according to the expres-
sion of CCR7, CD45RA and cytolytic effector molecules
[15-17]. The expression of CCR7 divides human memory
T cells into two functionally distinct subsets with distinct
homing capacity and effector function [15,16]: those
expressing CCR7 are termed central memory (CM),
whereas effector memory (EM) cells are characterised by
the lack of CCR7. Whereas CM CD8 T cells are phenotyp-
ically homogeneous, different EM subpopulations have
been defined within the CCR7null subset according to the
expression of different markers including the level of
expression of CD45RA or the expression of the co-stimu-
latory molecules CD27 and CD28 [18-20].
In vitro senescence models and cross-sectional ex vivo
studies have consistently demonstrated that senescent T
cells and T cells from aged individuals express unusually
high densities of receptors that are normally found on nat-
ural killer (NK) cells [21,22]. On CD8 T cells, the expres-
sion of NK associated receptors increases with age whereas
expression of CCR7 decreases [23]. CD85j (also called
LIR-1/ILT2/LILRB1), is an inhibitory cell surface receptor
expressed on NK cells, B lymphocytes, monocytes, den-
dritic cells, and T cell subsets. CD85j recognises a broad
range of classical and non-classical MHC class I molecules
and CD85j triggering inhibits T cell function [24,25]. In
contrast, CD85j interaction with UL18, an MHC class I
homologue encoded by human cytomegalovirus, leads to
activation of T cells, resulting in lysis of CMV-infected
cells [26,27]. The expression of CD85j has been correlated
with CD8 T-cell differentiation into effector cells and it is
increased on virus-specific CD8 T cells in chronic infec-
tion [25]. CD244 (2B4) is a transmembrane receptor of
the Ig superfamily primarily expressed by NK cells and
antigen-experienced CD8 T cell subsets [28,29]. It is
required for optimal activation of CD8 T cells and NK
cells [30] playing an important role in activating cytotox-
icity through its interaction with CD48 on some target
cells [28,29,31].
In this study, we analyse the effect of ageing on the fre-
quency of total and CMV-specific CD8 T cell subsets
defined by the expression of CCR7 and CD45RA. Using
these markers we have defined naïve (CCR7+
CD45RAbright), CM (CCR7+ CD45RAnulls) and three sub-
populations of EM CD8 T cells, characterised by the
absence of CCR7, and defined according to the level of
expression of CD45RA as EMRAnull, EMRAdim  and
EMRAbright (Figure 1). The expression of CD27, CD28 and
the NK cell-associated markers CD85j and CD244 on
these subsets is also studied.
Results
The frequency of CMV pp65-specific CD8 T cells is 
increased in healthy elderly when compared with young 
and middle aged individuals
The analysis of the frequencies of CMV pp65-specific CD8
T cells in HLA-A2, CMV-seropositive donors using A2/
CMV-pp65 pentamers is shown in Figure 2. Pentamer-
positive CD8 T cells were increased in the elderly com-
pared with young (p = 0.03) and middle aged (p = 0.027)
donors. No significant differences were observed when
values from young and middle aged donors were com-
pared.
Age-associated expansion of effector-memory CMVpp65-
specific CD8 T cells
Age-associated changes in naive, CM and the three subsets
of EM (EMRAnull, EMRAdim and EMRAbright) in pentamer-
positive and pentamer-negative CD8 T cells are shown in
Figure 3. The results demonstrated that the proportion of
naïve A2/CMV-pp65 pentamer-positive CD8 T cells wereImmunity & Ageing 2009, 6:11 http://www.immunityageing.com/content/6/1/11
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significantly reduced in elderly individuals compared
with young donors (p = 0.007) (Figure 3A). No significant
changes on CM pentamer-positive CD8 T cells were found
(Figure 3C). When pentamer-negative CD8 T cells were
analysed an age-associated decrease in the proportion of
naïve cells (elderly vs young p < 0.001 and elderly vs mid-
dle aged p = 0.003) and CM (elderly vs young p = 0.002),
(Figure 3B and 3D) were found, corroborating that the
proportions of these CD8 T cell subsets are decreased with
age.
In relation with the EM subsets, the results showed, both
in the pentamer-positive and pentamer-negative CD8 T
cells, an age-associated increase of the percentage of
EMRAdim cells (Figure 3G and 3H), whereas no significant
differences were found in the EMRAbright (Figure 3E and
3F) or in the EMRAnull (Figure 3I and 3J) subsets. No sig-
nificant differences in the distribution of naïve/memory
CD8 T cell subsets have been found when comparing pen-
tamer-positive and pentamer-negative CD8 T cells in each
age group.
Decreased expression of CD27 and CD28 on the EM CD8 
T cell subsets in the elderly
In order to further characterise age-associated changes in
the CCR7null EM T cell subsets, the expression of CD27
and CD28 was analysed. The results showed that the
EMRAnull subset had a higher expression of both CD27
and CD28 markers than the EMRAdim and EMRAbright sub-
sets in the groups of young, middle age and elderly
donors. Furthermore, a decreased expression of CD27 was
observed in the middle age and elderly group compared
with young individuals in the three EM subsets considered
(Figure 4A). A similar age-associated decrease was
observed in the expression of CD28 in the EMRAdim and
EMRAbright subsets, whereas no significant age-associated
differences were found in the expression of CD28 within
the EMRAnull subset (Figure 4B).
Most A2/CMV-pp65 pentamer-positive CD8 T cells from 
elderly individuals are CD27 and CD28 negative cells 
expressing CD85j and CD244
The analysis of CD27 and CD28 expression in CMV pp65-
specific CD8 T cells demonstrated that elderly individuals
had an increased proportion of CD27-CD28- cells com-
pared with young (p < 0.001) and middle aged (p < 0.001)
donors (Figure 5A). Although, an age-associated increase
of CD27-CD28- cells was also found in A2/CMV-pp65
pentamer-negative CD8 T cells, no significant statistical
differences were found (Figure 5B).
To further characterise the phenotype of CMV pp65-spe-
cific CD8 T cells we have analysed the expression of
CD85j, a receptor for the human CMV MHC class I homo-
logue UL18. Our results showed an increased expression
of CD85j both in A2/CMV-pp65 pentamer-positive and
pentamer-negative CD8 T cells from elderly individuals
when compared with young and middle aged donors (Fig-
ure 5C and 5D). An age-associated increase in the expres-
sion of CD244 on CD8 T cells was also found in
CD8 T cell-subset distribution according to the expression of CCR7 and CD45RA Figure 1
CD8 T cell-subset distribution according to the expression of CCR7 and CD45RA. Schematic representation (left) 
and a representative experiment (right) of the five CD8 T cell subsets that can be defined by the analysis of CCR7 and 
CD45RA markers.
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pentamer-negative CD8 T cells. Statistically significant dif-
ferences were observed when elderly donors were com-
pared with young (p = 0.044) and middle aged (p = 0.042)
individuals whereas no statistical significant differences
were found in the expression of CD244 when CMV pp65-
specific T cells were considered (Figure 5E and 5F). Repre-
sentative flow cytometry analyses of the expression of
CD85j and CD244 in pentamer-positive and negative
CD8 T cells from young, middle-aged and elderly individ-
uals are shown in Figure 6.
Discussion
In this work the effect of ageing on the frequency and phe-
notype of CMV-specific CD8 T cell subsets has been stud-
ied. Increasing evidences support that many of the
alterations observed in the T cell compartment in the eld-
erly can be the consequence of chronic activation of the
immune system by latent virus such as CMV [9,10,13,32-
40]. Thus remodelling of the CD8 T cell compartment in
the elderly, characterised by a decrease of naive cells and
increasing numbers of cells with a memory/activated phe-
notype [13,41-48], could be a consequence not only of
thymic involution (changes related to age) but also due to
CMV chronic antigenic stimulation as recently indicated
[4,5,10,13,49].
An increased frequency of CMV-specific CD8 T cells was
observed in the elderly compared to young and middle
aged individuals. Our results on the analysis of the effect
of ageing on the phenotype of CMV-specific CD8 T cells
show that elderly individuals have a decrease of A2/
CMVpp65 pentamer-positive CD8 T cells with a naive
phenotype and an increase of those with an EM pheno-
type, compared with young individuals [10,13]. The
increase in the EM subset is mainly due to the expansion
of those A2/CMVpp65 pentamer-positive CD8 T cells dis-
playing the EMRAdim phenotype, whereas the percentage
values of EMRAbright and EMRAnull CD8 T cells were similar
in young, middle aged and elderly donors.
The CD8 T cell compartment as a whole showed a
decreased frequency of naive and CM cells and an increase
of the EMRAdim CD8 T cell subset. These results confirm
previous studies showing a dramatic decrease in the per-
centage of naive and the expansion of EM CD8 T cells with
age [10,48,50]. The decreased percentage of naive CD8 T
cells (defined as CCR7+ CD45RA+ CD28+ CD27+) and
the expansion of EM CD8 T cells, showing a wide range of
phenotypes [19], have been used in several studies as
biomarkers of immunosenescence [38,40,48]. A recent
study that analyses age-associated changes in CD8 cells in
CMV seronegative and seropositive individuals strongly
support that CMV is the predominant stimulus for the
generation of CD45RA+ EM CD8 cells [4]. However, our
results showing that there are not remarkable differences
in the naïve/and different memory T cells between A2/
CMV-pp65 -specific and non specific CD8 T cells, suggest
that this is not the unique chronic stimulus as previously
demonstrated in the northern European population and
in CMV-negative elderly donors [4,5,7,51,52].
The expression of the CD28- phenotype is a characteristic
of replicative senescence [53,54]. Chronic antigenic stim-
ulation has been associated with peripheral blood expan-
sions of CD28- CD8 T cells also characterised by loss of
CD27 and expression of NK cell-associated markers as
CD57 [22,28,55-57]. We observed an increase of CMV-
specific CD8 T cells displaying a CD27-CD28- phenotype
in the elderly suggesting that clonal expansion of T cells in
response to chronic antigenic stimulation results in the
accumulation of senescent T cells. In the pentamer-nega-
tive CD8 T cells a similar tendency was observed in the
expression of CD27 and CD28 although no significant
differences were observed between young, middle aged
and elderly individuals.
CD85j is an inhibitory cell surface receptor that has high
affinity for UL18, an MHC class I homologue encoded by
Elderly individuals show an increased frequency of  CMVpp65-specific CD8 T cells Figure 2
Elderly individuals show an increased frequency of 
CMVpp65-specific CD8 T cells. The frequency of A2/
CMVpp65 pentamer-positive CD8 T cells was analysed in 
young, middle aged and elderly donors. Data are presented 
as diagrams of boxes; the lower boundary of the box indi-
cates the 25th percentile and the upper boundary the 75th 
percentile. Error bars above and below the box indicate the 
90th and 10th percentiles. A line within the box marks the 
median. Outliers are represented as individual points. P val-
ues lower than 0.05 were considered statistically significant.
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Influence of age on CD8 T cell subset distribution Figure 3
Influence of age on CD8 T cell subset distribution. According to the subset model depicted in Figure 1, CD8 T cells 
were subdivided into naive, CM, EMRAbright, EMRAdim, EMRAnull cells and analysed in young, middle aged and elderly individuals. 
Results for CMV pentamer-positive (left) and pentamer-negative (right) CD8 T cells are shown. Data are presented as dia-
grams of boxes as indicated in Figure 2 legend.
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human cytomegalovirus. Despite the well defined inhibit-
ing functions of CD85j, its interaction with UL18 leads to
activation of T cells, resulting in lysis of CMV-infected
cells [26,27]. CD85j expression has been correlated with
CD8 T-cell differentiation into effector cells [25]. An age-
associated increase of CD85j on CD8 T cells has been
reported that correlates with CD28 down-regulation and
CD57 up-regulation [23,58,59]. Here we show that eld-
erly individuals have an increased expression of CD85j
within both CMV-specific and pentamer-negative CD8 T
cells. Thus, its expression could be used as an indicator of
the encounter with CMV pp65 epitope presented by the
APCs to CD8 T cells. In addition, CD85j expression could
be a used as a marker of replicative senescence [23,59], in
parallel with the CD27- CD28- phenotype or CD57 expres-
sion. CD85j+ CD27- CD28- CMV pp65-specific CD8 T cells
were increased in the elderly compared with young and
middle aged suggesting that CMV-specific CD8 T cells
have undergone extensive rounds of CMV antigen-driven
stimulation reaching replicative senescence. The expres-
sion of CD244, a marker of T cell differentiation into
effector cells [60,61], was found elevated in CMV-specific
CD8 T cells compared to whole CD8 T cells.
Similar frequencies of CMV-specific CD8 T cells and T cell
subsets defined by CCR7 and CD45RA can be found in
young and middle-age donors. The high variability
observed in the middle aged population could be related
to the time point of CMV infection or the different
immune response from each individual to virus. It should
be interesting to know the evolution of those individuals
in this age-group. It can be speculated that chronic activa-
tion of CMV-specific CD8 T cells in young and middle
aged donors might have detrimental effects on age-associ-
ated diseases in this population.
Conclusion
It has been demonstrated that naturally occurring CD4
and CD8 T cell responses to pp65 were detectable in many
subjects [62]. Phenotypic characterization of CMV-spe-
cific CD8 T cells can benefit the development of adoptive
therapies and vaccination protocols. The finding that the
CMV-specific CD8 T cell phenotype in elderly individuals
is similar to the predominant phenotype of CD8 T cells as
a whole, suggest that latent infection with CMV can be
considered as a major force contributing to the differenti-
ation of CD8 T cells into CD27- CD28- cells. These data
confirm that the chronic antigenic stimulation induced by
persistent viral life-long infections like CMV may induce
important changes in the CD8 T cell compartment.
Donors, materials and methods
Subjects
Peripheral blood from healthy donors was obtained after
informed consent under the auspices of the appropriate
Research and Ethics Committees. Eighteen healthy young
individuals (age range, 21 to 40 years; mean ± standard
deviation (SD), 29 ± 6 years), seventeen healthy middle
aged donors (age range, 41 to 64 years; mean ± SD, 51 ±
6 years) and fifteen healthy elderly donors (age range, 65
to 101 years, mean ± SD, 78 ± 7 years) were selected on
the basis of HLA-A*0201 expression and CMV seroposi-
tivity. Although elderly donors were not selected accord-
ing to the SENIEUR criteria, all individuals studied were in
good clinical condition. Peripheral blood mononuclear
cells (PBMC) were obtained by centrifugation over Histo-
paque-1077 (Sigma, St Louis, MO, USA). After washing,
Expression of CD27 and CD28 on the effector-memory  CD8 T cell subsets Figure 4
Expression of CD27 and CD28 on the effector-mem-
ory CD8 T cell subsets. EM CD8 T cells defined as 
CCR7null were subdivided into further subsets according to 
the model in Figure 1 and analysed in young, middle aged and 
elderly individuals. Columns and bars represent the mean 
and SD.Immunity & Ageing 2009, 6:11 http://www.immunityageing.com/content/6/1/11
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The majority of A2/CMV-pp65 pentamer-positive CD8 T cells from elderly individuals display a CD27- CD28- phenotype and  express CD85j and CD244 Figure 5
The majority of A2/CMV-pp65 pentamer-positive CD8 T cells from elderly individuals display a CD27- CD28- 
phenotype and express CD85j and CD244. The percentage of CD27-CD28- (A), CD85j+ (B) and CD244+ (C) CD8 T cells 
was analysed on PBMC gated on CMV pentamer-positive (left) and pentamer-negative (right) CD8 T cells in young, middle 
aged and elderly donors. Data are presented as diagrams of boxes as indicated in Figure 2 legend.
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PBMC were resuspended in phosphate-buffered saline
(PBS) and used for flow cytometry analysis.
Reagents and Monoclonal Abs
For multiparametric flow cytometry the following mono-
clonal antibodies (mAbs) were used: peridinin chloro-
phyll protein (PerCP)-conjugated anti-CD8 (SKI);
phycoerythrin (PE) conjugated anti-CCR7 (2H4); fluores-
cein isothiocyanate (FITC) conjugated anti-CD45RA
(L48); FITC- and allophycocyanin (APC)-conjugated anti-
CD27 (L128); PE- and APC-conjugated anti-CD28
(CD28.2); FITC-conjugated anti-CD244 (C1.7) and FITC-
conjugated anti-CD85j (GHI/75). Isotype controls
labeled with the different fluorochromes were used in all
the experiments. All mAbs were purchased from BD Bio-
sciences (San Jose, CA). The HLA-A*0201/CMV pp65495–
504(NLVPMVATV) pentamer (A2/CMV-pp65), APC-con-
jugated, was purchased from Proimmune (Oxford, UK).
Cell surface staining and flow cytometry
For cell surface staining, 2–2.5 × 106 PBMC were incu-
bated with A2/CMV-pp65 pentamer, labelled with APC.
Staining was performed according to the specifications
given by the manufacturer. Cells were then washed and
stained with the appropriate combination of mAbs spe-
cific for CD8, CCR7, CD45RA, CD27, CD28, CD244 and
CD85j for 30 min at 4°C. Subsequently, cells were
washed twice with PBS and resuspended in FACS buffer.
Flow cytometric analysis was performed on a FACScalibur
and FACSCanto cytometers (BD Biosciences). Viable cells
were selected using forward and side scatter characteris-
tics. The frequency of A2/CMVpp65 pentamer-positive
cells was referred to the CD8bright T cell population. The
expression of the different markers was referred to the A2/
CMV-pp65 pentamer-positive T cells or to the pentamer-
negative CD8bright T cells as indicated. Resulting profiles
were analysed using Cell Quest software (BD Biosciences).
Statistical analysis
SPSS for Windows version 11.5 (SPSS Inc., Chicago) was
used for statistical analysis. Comparisons between young,
middle aged, and elderly donors were done by analysis of
sample normality and variance followed by post hoc mul-
tiple comparisons. The tests of Hochberg or Games-How-
ell were applied for samples with equal or unequal
variances respectively. P values of less than 0.05 were con-
sidered statistically significant. Data are presented as dia-
grams of boxes; the lower boundary of the box indicates
the 25th percentile and the upper boundary the 75th per-
centile. Error bars above and below the box indicate the
90th and 10th percentiles. A line within the box marks the
median. Outliers are represented as individual points.
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